Jon Cogan

924 total citations
23 papers, 667 citations indexed

About

Jon Cogan is a scholar working on Cell Biology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jon Cogan has authored 23 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cell Biology, 10 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Jon Cogan's work include Skin and Cellular Biology Research (12 papers), Autoimmune Bullous Skin Diseases (9 papers) and Prostate Cancer Treatment and Research (4 papers). Jon Cogan is often cited by papers focused on Skin and Cellular Biology Research (12 papers), Autoimmune Bullous Skin Diseases (9 papers) and Prostate Cancer Treatment and Research (4 papers). Jon Cogan collaborates with scholars based in United States, Switzerland and Israel. Jon Cogan's co-authors include David T. Woodley, Mei Chen, Baruch Frenkel, Yingping Hou, Gerhard A. Coetzee, Grant Buchanan, Douglas R. Keene, Chao Lyu, M. Peter Marinkovich and Jia Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Jon Cogan

21 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Cogan United States 13 337 253 140 138 119 23 667
Joëlle d'Anjou France 12 192 0.6× 160 0.6× 62 0.4× 80 0.6× 83 0.7× 21 584
Michael A. Haralson United States 16 308 0.9× 102 0.4× 80 0.6× 119 0.9× 45 0.4× 26 755
Shoju Hiraga Japan 13 364 1.1× 68 0.3× 69 0.5× 62 0.4× 143 1.2× 18 696
Maretoshi Hirai Japan 12 626 1.9× 167 0.7× 116 0.8× 403 2.9× 21 0.2× 17 992
Koji Takeda Japan 13 189 0.6× 81 0.3× 98 0.7× 70 0.5× 111 0.9× 31 609
Fredrik Wågberg Sweden 12 174 0.5× 161 0.6× 205 1.5× 68 0.5× 36 0.3× 15 786
Ricardo Celestino Portugal 17 390 1.2× 209 0.8× 81 0.6× 107 0.8× 119 1.0× 27 838
Motomi Enomoto Japan 12 346 1.0× 135 0.5× 29 0.2× 73 0.5× 31 0.3× 16 625
Ylva Paulsson Sweden 14 501 1.5× 86 0.3× 82 0.6× 71 0.5× 21 0.2× 17 803
Julian Nüchel Germany 12 304 0.9× 118 0.5× 46 0.3× 34 0.2× 40 0.3× 14 634

Countries citing papers authored by Jon Cogan

Since Specialization
Citations

This map shows the geographic impact of Jon Cogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Cogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Cogan more than expected).

Fields of papers citing papers by Jon Cogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Cogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Cogan. The network helps show where Jon Cogan may publish in the future.

Co-authorship network of co-authors of Jon Cogan

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Cogan. A scholar is included among the top collaborators of Jon Cogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Cogan. Jon Cogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sadeghi, Sarmad, Nataliya Mar, Denice Tsao‐Wei, et al.. (2024). Association of ephrinB2 (B2) expression on overall survival (OS) and resistance to PD1/L1 inhibitors (inh) in metastatic urothelial carcinoma (mUC).. Journal of Clinical Oncology. 42(16_suppl). 4577–4577.
2.
Woodley, David T., Jon Cogan, Yingping Hou, et al.. (2024). Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial. British Journal of Dermatology. 191(2). 267–274. 7 indexed citations
3.
Lyu, Chao, David T. Woodley, Dédée F. Murrell, et al.. (2021). Over‐expression of stromal periostin correlates with poor prognosis of cutaneous squamous cell carcinomas. Experimental Dermatology. 30(5). 698–704. 12 indexed citations
4.
Woodley, David T., et al.. (2021). Characterization of mutant type VII collagens underlying the inversa subtype of recessive dystrophic epidermolysis bullosa. Journal of Dermatological Science. 104(2). 104–111. 3 indexed citations
5.
Antaya, Richard J., Jon Cogan, Claire Hamilton, et al.. (2020). 861 Intravenous gentamicin therapy for junctional epidermolysis bullosa patients harboring nonsense mutations. Journal of Investigative Dermatology. 140(7). S112–S112. 2 indexed citations
6.
Cogan, Jon, Yingping Hou, Richard J. Antaya, et al.. (2020). Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations. Molecular Therapy. 28(5). 1327–1338. 42 indexed citations
7.
Woodley, David T., Ava Kwong, Jon Cogan, et al.. (2019). 1021 Intravenous gentamicin therapy for recessive dystrophic epidermolysis bullosa patients harboring nonsense mutations. Journal of Investigative Dermatology. 139(5). S176–S176. 3 indexed citations
8.
Cogan, Jon, Yingping Hou, Vitali Alexeev, et al.. (2018). Gentamicin inducesLAMB3nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa. Proceedings of the National Academy of Sciences. 115(28). E6536–E6545. 52 indexed citations
9.
Chen, Mei, Jon Cogan, Yiping Hou, Douglas R. Keene, & David T. Woodley. (2017). 299 Gentamicin therapy induced functional type VII collagen in recessive dystrophic epidermolysis bullosa patients harboring nonsense mutations. Journal of Investigative Dermatology. 137(5). S51–S51.
10.
Woodley, David T., Jon Cogan, Yingping Hou, et al.. (2017). Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients. Journal of Clinical Investigation. 127(8). 3028–3038. 85 indexed citations
11.
Cogan, Jon, et al.. (2016). 389 Pirfenidone inhibits RDEB fibrosis and scarring. Journal of Investigative Dermatology. 136(5). S69–S69. 1 indexed citations
12.
Hou, Yingping, Lin T. Guey, Timothy Wu, et al.. (2015). Intravenously Administered Recombinant Human Type VII Collagen Derived from Chinese Hamster Ovary Cells Reverses the Disease Phenotype in Recessive Dystrophic Epidermolysis Bullosa Mice. Journal of Investigative Dermatology. 135(12). 3060–3067. 28 indexed citations
13.
Cogan, Jon, Xinyi Wang, Yingping Hou, et al.. (2014). Aminoglycosides Restore Full-length Type VII Collagen by Overcoming Premature Termination Codons: Therapeutic Implications for Dystrophic Epidermolysis Bullosa. Molecular Therapy. 22(10). 1741–1752. 49 indexed citations
14.
Gabet, Yankel, Sanjeev K. Baniwal, Nathalie Leclerc, et al.. (2010). Krox20/EGR2 deficiency accelerates cell growth and differentiation in the monocytic lineage and decreases bone mass. Blood. 116(19). 3964–3971. 32 indexed citations
15.
Gabet, Yankel, Jon Cogan, Yunfan Shi, et al.. (2009). Lef1 Haploinsufficient Mice Display a Low Turnover and Low Bone Mass Phenotype in a Gender- and Age-Specific Manner. PLoS ONE. 4(5). e5438–e5438. 58 indexed citations
16.
Li, Jia, Benjamin P. Berman, Xiting Yan, et al.. (2008). Genomic Androgen Receptor-Occupied Regions with Different Functions, Defined by Histone Acetylation, Coregulators and Transcriptional Capacity. PLoS ONE. 3(11). e3645–e3645. 116 indexed citations
17.
Cogan, Jon, et al.. (2008). Inhibition of AR‐mediated transcription by binding of Oct1 to a motif enriched in AR‐occupied regions. The Prostate. 69(4). 392–400. 8 indexed citations
18.
Prescott, Jennifer, Jia Li, Artem Barski, et al.. (2007). Identification of novel androgen receptor target genes in prostate cancer. Molecular Cancer. 6(1). 39–39. 84 indexed citations
19.
Prescott, Jennifer, Jia Li, Jon Cogan, et al.. (2007). Androgen receptor‐mediated repression of novel target genes. The Prostate. 67(13). 1371–1383. 31 indexed citations
20.
Leclerc, Nathalie, et al.. (2007). Opposing effects of glucocorticoids and Wnt signaling on Krox20 and mineral deposition in osteoblast cultures. Journal of Cellular Biochemistry. 103(6). 1938–1951. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joëlle d'Anjou Breakdown of academic impact, for papers by Michael A. Haralson Breakdown of academic impact, for papers by Shoju Hiraga Breakdown of academic impact, for papers by Maretoshi Hirai Breakdown of academic impact, for papers by Koji Takeda Breakdown of academic impact, for papers by Fredrik Wågberg Breakdown of academic impact, for papers by Ricardo Celestino Breakdown of academic impact, for papers by Motomi Enomoto Breakdown of academic impact, for papers by Ylva Paulsson Breakdown of academic impact, for papers by Julian Nüchel
Rankless by CCL
2026